Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysisHisham Mehanna, Sara Tous, Jill Brooks et al.|The Lancet Oncology|2023Cited by 291
911O Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC StudyHisham Mehanna, Laia Alemany, M. Taberna Sanz et al.|Annals of Oncology|2020Cited by 3